ZA814430B - Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator - Google Patents

Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator

Info

Publication number
ZA814430B
ZA814430B ZA814430A ZA814430A ZA814430B ZA 814430 B ZA814430 B ZA 814430B ZA 814430 A ZA814430 A ZA 814430A ZA 814430 A ZA814430 A ZA 814430A ZA 814430 B ZA814430 B ZA 814430B
Authority
ZA
South Africa
Prior art keywords
therapeutical
useful
pharmaceutical composition
diagnostic use
feed integrator
Prior art date
Application number
ZA814430A
Other languages
English (en)
Inventor
Massimo Baldacci
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Publication of ZA814430B publication Critical patent/ZA814430B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA814430A 1980-06-30 1981-06-30 Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator ZA814430B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23101/80A IT1131854B (it) 1980-06-30 1980-06-30 Composizione farmaceutica per uso terapeutico,per uso diagnostico e quale integratore alimentare

Publications (1)

Publication Number Publication Date
ZA814430B true ZA814430B (en) 1982-09-29

Family

ID=11203787

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA814430A ZA814430B (en) 1980-06-30 1981-06-30 Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator

Country Status (9)

Country Link
JP (1) JPS5714530A (xx)
AU (1) AU560450B2 (xx)
CH (1) CH649222A5 (xx)
DE (1) DE3115322A1 (xx)
FR (1) FR2485371A1 (xx)
GB (1) GB2078516B (xx)
IT (1) IT1131854B (xx)
PT (1) PT73286B (xx)
ZA (1) ZA814430B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314079A1 (de) * 1982-04-19 1983-12-22 Papst Motoren Gmbh & Co Kg Mehrwellenlaufwerk fuer kassetierte signaltraeger
DE3242501C1 (de) * 1982-11-18 1984-03-29 Degussa Ag, 6000 Frankfurt Verwendung von waessrigen L-Lysin-Loesungen zur Supplementierung von Futtermitteln mit L-Lysin
FR2568124B1 (fr) * 1984-07-24 1988-12-09 Cortial Medicament pour traiter les etats hypotrophiques par administrations d'aspartate d'arginine
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
US5077313A (en) * 1988-11-25 1991-12-31 Gert Lubec Process for inhibiting pathological collagen cross-linking in diabetes patients
AT393080B (de) * 1988-11-25 1991-08-12 Lubec Gert Pharmazeutische verwendung von arginin (salzen)
US6143786A (en) * 1999-02-02 2000-11-07 Novartis Nutrition Ag Oral arginine and insulin secretion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6588M (xx) * 1967-10-11 1968-12-30

Also Published As

Publication number Publication date
AU7233681A (en) 1982-01-14
GB2078516A (en) 1982-01-13
GB2078516B (en) 1985-02-27
DE3115322A1 (de) 1982-04-08
FR2485371B1 (xx) 1985-04-12
PT73286B (en) 1982-07-22
JPS5714530A (en) 1982-01-25
PT73286A (en) 1981-07-01
IT1131854B (it) 1986-06-25
FR2485371A1 (fr) 1981-12-31
CH649222A5 (it) 1985-05-15
AU560450B2 (en) 1987-04-09
IT8023101A0 (it) 1980-06-30

Similar Documents

Publication Publication Date Title
DE3269625D1 (en) Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and the compounds for therapeutical use
DE3069559D1 (en) Beta-carbolin-3-carboxylic acid derivatives, pharmaceutical compositions containing them and their therapeutical use
DE3372705D1 (en) Pharmaceutical composition and its use
DE3372066D1 (en) Pharmaceutical preparation for endermic use
PT74793B (en) Novel bandage for administering beneficial drug
DE3172028D1 (en) Pharmaceutical formulation
ZA834074B (en) Pharmaceutical composition
EP0093551A3 (en) Pharmaceutical composition
IL68292A0 (en) Pharmaceutical compositions containing dihydropyridines and their use for the treatment of animals
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
PT73286A (en) Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator
JPS5646806A (en) Medicinal composition containing paracetamol
ZA812034B (en) Phrimidyl-quinazolines,process for their preparation pharmaceutical formulations containing these compounds,and their use
GB2105992B (en) Pharmaceutical composition for treatment of cardio-vascular diseases
GB2073747B (en) Triazolopyridinone compounds process for the preparation thereof and pharmaceutical preparations containing them
DE3277171D1 (en) Pharmaceutical composition and the use of sn- or cr-protoporphyrin for the manufacture thereof
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
DE3362340D1 (en) A pharmaceutical composition and the use thereof for the treatment of inflammation
JPS55113713A (en) Paracetamol contained medical composition
GB8328896D0 (en) Pharmaceutical composition
DE3372968D1 (en) Heterocyclyl-thio compounds, process for their preparation, pharmaceutical compositions containing them and their use
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
ZA834539B (en) Pharmaceutical composition and its preparation and use
HK90087A (en) Pharmaceutical formulation
GB2089799B (en) Thiocarnitines process for their preparation and pharmaceutical compositions containing same